Scan to Download
One power score. Smarter investment decisions
BIOAGE Labs Inc
BIOA4.900USD
-0.320-6.13%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
175.67MMarket Cap
LossP/E TTM
BIOAGE Labs Inc
4.900
-0.320-6.13%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---19.97M
-10.79%-17.36M
---5.14M
---14.93M
---15.67M
Net income from continuing operations
---21.56M
0.49%-12.93M
---21.13M
---23.41M
---12.99M
Operating gains losses
--58.00K
12.12%37.00K
--47.00K
--38.00K
--33.00K
Other non-cash items
--60.00K
5200.00%53.00K
--0.00
--1.00K
--1.00K
Change in working capital
---1.79M
-60.26%-7.53M
--13.58M
--6.23M
---4.70M
-Change in receivables
---242.00K
---361.00K
----
----
--0.00
-Change in prepaid expenses
--135.00K
-25.93%-1.18M
---761.00K
---23.00K
---937.00K
-Change in other current assets
--2.00K
--1.00K
---240.00K
--25.00K
--0.00
-Change in other current liabilities
---1.81M
---1.09M
--12.50M
---3.31M
--0.00
Cash from non-recurring investing activities
Cash from operating activities
---19.97M
-10.79%-17.36M
---5.14M
---14.93M
---15.67M
Investing cash flow
Net cash from continuing investing activities
--159.00K
--426.00K
--26.00K
--305.00K
--0.00
Capital expenditures
--159.00K
--426.00K
--26.00K
--305.00K
--0.00
Net cash flow from disposal of fixed assets
--159.00K
--426.00K
--26.00K
--305.00K
--0.00
Net cash flow from investment products
---15.48M
---77.56M
----
----
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---15.64M
---77.99M
---26.00K
---305.00K
--0.00
Financing cash flow
Cash flow from continuous financing activities
---1.50M
-100.89%-1.50M
--24.90M
--190.68M
--168.00M
Net cash flow from debt Issuance/repayment
---1.50M
0.00%-1.50M
---1.50M
---1.50M
---1.50M
Net cash flow from common stock issuance/repurchase
--0.00
-100.00%0.00
--27.62M
--194.54M
--170.00M
Proceeds from stock option exercised by employees
--0.00
-100.00%0.00
--25.00K
--184.00K
--3.00K
Net cash flow from other financing activities
--0.00
100.00%0.00
---1.24M
---2.54M
---502.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
---1.50M
-100.89%-1.50M
--24.90M
--190.68M
--168.00M
Net cash flow
Beginning cash balance
--257.49M
1319.84%354.35M
--334.47M
--159.09M
--24.96M
Current period cash flow changes
---37.16M
-163.58%-96.86M
--19.88M
--175.39M
--152.35M
Effect of exchange rate changes
---46.00K
-163.16%-12.00K
--137.00K
---58.00K
--19.00K
Ending cash balance
--220.33M
45.22%257.49M
--354.35M
--334.47M
--177.31M
Free cash flow
---20.13M
-13.51%-17.79M
---5.16M
---15.24M
---15.67M
Currency unit
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
